Search This Blog

Monday, March 25, 2019

MediciNova asumed with a Buy at B. Riley FBR

B. Riley FBR analyst Chad Mabry assumed coverage of MediciNova with a Buy rating and $22 price target.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)